Cargando…

A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry

Jinshui-Huanxian granules (JHGs), a Chinese herbal compound prescription, have shown a therapeutic effect in reducing lung tissue damage, improving the degree of pulmonary fibrosis, replenishing lungs and kidneys, relieving cough and asthma, reducing phlegm, and activating blood circulation. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Weiwei, Wan, Yan, Sun, Shuding, Xie, Yang, Zhao, Di, Li, Bing, Li, Jiansheng, Tian, Yange, Feng, Suxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534582/
https://www.ncbi.nlm.nih.gov/pubmed/37764268
http://dx.doi.org/10.3390/molecules28186492
_version_ 1785112428468502528
author Zhang, Weiwei
Wan, Yan
Sun, Shuding
Xie, Yang
Zhao, Di
Li, Bing
Li, Jiansheng
Tian, Yange
Feng, Suxiang
author_facet Zhang, Weiwei
Wan, Yan
Sun, Shuding
Xie, Yang
Zhao, Di
Li, Bing
Li, Jiansheng
Tian, Yange
Feng, Suxiang
author_sort Zhang, Weiwei
collection PubMed
description Jinshui-Huanxian granules (JHGs), a Chinese herbal compound prescription, have shown a therapeutic effect in reducing lung tissue damage, improving the degree of pulmonary fibrosis, replenishing lungs and kidneys, relieving cough and asthma, reducing phlegm, and activating blood circulation. However, these active compounds’ pharmacokinetics and metabolic processes were unclear. This study aimed to compare the pharmacokinetics, reveal the metabolic dynamic changes, and obtain the basic pharmacokinetic parameters of 16 main bioactive compounds after intragastric administration of JHGs in control and pulmonary fibrosis (PF) model rats by using Orbitrap Fusion MS. After administration of JHGs, the rat plasma was collected at different times. Pretreating the plasma sample with methanol and internal standard (IS) solution carbamazepine (CBZ), and it was then applied to a C(18) column by setting gradient elution with a mobile phase consisting of methanol 0.1% formic acid aqueous solution. Detection was performed on an electrospray ionization source (ESI), and the scanning mode was SIM. Pharmacokinetic parameters were analyzed according to the different analytes’ concentrations in plasma. The matrix effect was within the range of 79.01–110.90%, the extraction recovery rate was 80.37–102.72%, the intra-day and inter-day precision relative standard deviation (RSD) was less than 7.76%, and the stability was good, which met the requirements of biological sample testing. The method was validated (r ≥ 0.9955) and applied to compare the pharmacokinetic profiles of the control group and PF model group after intragastric administration of the JHGs. The 16 analytes exhibited different pharmacokinetic behaviors in vivo. In the pathological state of the PF model, most of the components were more favorable for metabolism and absorption, and it was more meaningful to study the pharmacokinetics. Above all, this study provided an essential reference for exploring the mechanism of action of JHGs and guided clinical medication as well.
format Online
Article
Text
id pubmed-10534582
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105345822023-09-29 A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry Zhang, Weiwei Wan, Yan Sun, Shuding Xie, Yang Zhao, Di Li, Bing Li, Jiansheng Tian, Yange Feng, Suxiang Molecules Article Jinshui-Huanxian granules (JHGs), a Chinese herbal compound prescription, have shown a therapeutic effect in reducing lung tissue damage, improving the degree of pulmonary fibrosis, replenishing lungs and kidneys, relieving cough and asthma, reducing phlegm, and activating blood circulation. However, these active compounds’ pharmacokinetics and metabolic processes were unclear. This study aimed to compare the pharmacokinetics, reveal the metabolic dynamic changes, and obtain the basic pharmacokinetic parameters of 16 main bioactive compounds after intragastric administration of JHGs in control and pulmonary fibrosis (PF) model rats by using Orbitrap Fusion MS. After administration of JHGs, the rat plasma was collected at different times. Pretreating the plasma sample with methanol and internal standard (IS) solution carbamazepine (CBZ), and it was then applied to a C(18) column by setting gradient elution with a mobile phase consisting of methanol 0.1% formic acid aqueous solution. Detection was performed on an electrospray ionization source (ESI), and the scanning mode was SIM. Pharmacokinetic parameters were analyzed according to the different analytes’ concentrations in plasma. The matrix effect was within the range of 79.01–110.90%, the extraction recovery rate was 80.37–102.72%, the intra-day and inter-day precision relative standard deviation (RSD) was less than 7.76%, and the stability was good, which met the requirements of biological sample testing. The method was validated (r ≥ 0.9955) and applied to compare the pharmacokinetic profiles of the control group and PF model group after intragastric administration of the JHGs. The 16 analytes exhibited different pharmacokinetic behaviors in vivo. In the pathological state of the PF model, most of the components were more favorable for metabolism and absorption, and it was more meaningful to study the pharmacokinetics. Above all, this study provided an essential reference for exploring the mechanism of action of JHGs and guided clinical medication as well. MDPI 2023-09-07 /pmc/articles/PMC10534582/ /pubmed/37764268 http://dx.doi.org/10.3390/molecules28186492 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhang, Weiwei
Wan, Yan
Sun, Shuding
Xie, Yang
Zhao, Di
Li, Bing
Li, Jiansheng
Tian, Yange
Feng, Suxiang
A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry
title A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry
title_full A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry
title_fullStr A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry
title_full_unstemmed A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry
title_short A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry
title_sort pharmacokinetic study of sixteen major bioactive components of jinshui-huanxian granules in pulmonary fibrosis model and control rats using orbitrap fusion mass spectrometry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534582/
https://www.ncbi.nlm.nih.gov/pubmed/37764268
http://dx.doi.org/10.3390/molecules28186492
work_keys_str_mv AT zhangweiwei apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT wanyan apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT sunshuding apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT xieyang apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT zhaodi apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT libing apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT lijiansheng apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT tianyange apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT fengsuxiang apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT zhangweiwei pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT wanyan pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT sunshuding pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT xieyang pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT zhaodi pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT libing pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT lijiansheng pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT tianyange pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry
AT fengsuxiang pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry